BGNE

BGNE

BeiGene Ltd. American Depositary Shares

$0.000+0.000 (0.000%)

Real-time Price

Price Chart

No chart data available

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.000

High

$0.000

Low

$0.000

Volume

N/A

Company Fundamentals

Trading Stats

Related News

BusinessWire

BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Positive opinion for first-line treatment of extensive-stage small cell lung cancer based on results of RATIONALE-312 study demonstrating statistically significant overall survival benefit for TEVIMBRA in combination

View more
BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer